Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Parkinson Disease & Parkinson like Disorders
Age: Adult
Condition: Initial
Dose: Immediate release Tablet – Carbidopa/Levodopa 25 mg/100 mg
Frequency: three times daily
Note: Levodopa may be increased by 100 mg/day every 1-2 days; Carbidopa should be 70-100 mg/day but not to exceed 200 mg/day; levodopa not to exceed 800 mg/day; Maintain patients on the lowest dosage required to achieve symptomatic control and to minimize adverse reactions such as dyskinesia and nausea
Indication: Parkinson Disease & Parkinson like Disorders
Age: Adult
Condition: Initial
Dose: Immediate release Tablet – Carbidopa/Levodopa 10 mg/100 mg
Frequency: three or four times daily by mouth
Note: Levodopa may be increased by 100 mg/day every 1-2 days; Carbidopa should be 70-100 mg/day but not to exceed 200 mg/day; levodopa not to exceed 800 mg/day; Maintain patients on the lowest dosage required to achieve symptomatic control and to minimize adverse reactions such as dyskinesia and nausea

Child Dose

Clinical InformationAdministration Information
Age: Child
Dose: Tablet – Safety and efficacy not established
Note: Safety and efficacy not established

Renal Dose

Clinical InformationAdministration Information
Condition: Renal impairment
Dose: Not specified
Note: Safety and efficacy not established; use with caution
Administration
  • Can be taken with or without food
  • Space doses evenly
Side Effect

Drug Interaction

Drug NameRisk Factors
Pyridoxine
Reverses effects of levodopa
Type-B MAOIs (Phenelzine, Tranylcypromine, Selegiline, Moclobemide)
Synergistic effect

Disease Interaction

Disease NameRisk Factors
Narrow Angle Glaucoma
Can dangerously increase eye pressure
Melanoma
Can accelerate cancer growth

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store in a cool and dry place, protected from light.

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.